Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of NBP606 vs Prodiax-23 in Adults 50+ Years
NCT02079207Phase 3Completed
- Sponsor
- SK Chemicals
- Start
- Dec 2013
- Primary completion
- Oct 2014
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of NBP606 in pneumococcal infection, sponsored by SK Chemicals. Started Dec 2013; status: completed.
02
Drugs
NBP606
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT02079207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02079207.